IVRN — Innoveren Scientific Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.58m
- $0.45m
Annual balance sheet for Innoveren Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.07 | 1.42 | 1.64 | 0.095 | 0 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.02 | 0.041 | 0.022 | 0.057 | 0.029 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.15 | 2.28 | 1.76 | 0.197 | 0.084 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.267 | 0.958 | 0.418 | 0.038 | 0.02 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.455 | 3.27 | 2.2 | 0.321 | 0.137 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.19 | 5.77 | 2.89 | 4.92 | 7.48 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.15 | 12.4 | 2.88 | 4.98 | 9.49 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -5.7 | -9.09 | -0.678 | -4.66 | -9.36 |
Total Liabilities & Shareholders' Equity | 0.455 | 3.27 | 2.2 | 0.321 | 0.137 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |